Santhera Pharmaceuticals announces the appointment of Orlando Oliveira as Chief Executive Officer (CEO), effective July 15, 2026. He succeeds Dario Eklund, who will step...
Catalyst Pharmaceuticals, Inc. ("Catalyst"), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, announced that...
